Convenient Metformin Delivery Solutions for Modern Healthcare

We have developed a gummy form of Metformin to improve patient compliance, reduce GI-related adverse effects, and enhance bioavailability for those with type 2 diabetes (T2D) and polycystic ovary syndrome (PCOS).

Metformin is the most prescribed drug for managing type 2 diabetes, used by over 150 million people worldwide. It’s known for its efficacy in lowering blood sugar levels and is considered one of the safest pharmacological options available for diabetes treatment.

Absolutely. Metformin offers cardiovascular benefits, such as lower rates of death due to cardiovascular disease, and may aid in weight management. It’s also prescribed off-label for conditions like prediabetes, gestational diabetes, polycystic ovary syndrome (PCOS), and to counteract weight gain from antipsychotic medicines. Ongoing research is exploring its potential to lower cancer risk, reduce dementia and stroke rates, slow aging, prevent age-related diseases, and increase lifespan.

The discontinuation and nonadherence rates for Metformin can be as high as 46%, mainly due to gastrointestinal side effects. Patients are encouraged to discuss any adverse effects with their healthcare provider, as there may be alternative dosing strategies or formulations that can minimize side effects.

While Metformin is safe for most patients, up to 75% of individuals may experience gastrointestinal side effects. These can include diarrhea, nausea, vomiting, abdominal discomfort, and flatulence. The severity of these side effects varies, and they are more commonly associated with the immediate-release formulations of Metformin.